Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,154
archived clinical trials in
Other Indications

Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Status: Enrolling
Updated:  11/7/2012
Wound Institute & Research Center
mi
from
Dunmore, PA
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Status: Enrolling
Updated: 11/7/2012
Wound Institute & Research Center
mi
from
Dunmore, PA
Click here to add this to my saved trials
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Status: Enrolling
Updated:  11/7/2012
Lake Washington Vascular Surgeons
mi
from
Bellevue, WA
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Status: Enrolling
Updated: 11/7/2012
Lake Washington Vascular Surgeons
mi
from
Bellevue, WA
Click here to add this to my saved trials
Impact of Vitamin D Supplementation on Cardiometabolic Risk Factors [The Daily D Health Study]
The Impact of Vitamin D Supplementation on Cardiometabolic Risk Factors in Schoolchildren
Status: Enrolling
Updated:  11/21/2012
Tufts University
mi
from
Boston, MA
Impact of Vitamin D Supplementation on Cardiometabolic Risk Factors [The Daily D Health Study]
The Impact of Vitamin D Supplementation on Cardiometabolic Risk Factors in Schoolchildren
Status: Enrolling
Updated: 11/21/2012
Tufts University
mi
from
Boston, MA
Click here to add this to my saved trials
Laparoscopic Versus Open Appendectomy? Let the Patient Decide
Laparoscopic Versus Open Appendectomy? Let the Patient Decide
Status: Enrolling
Updated:  11/27/2012
Primary Children's Hospital
mi
from
Salt Lake City, UT
Laparoscopic Versus Open Appendectomy? Let the Patient Decide
Laparoscopic Versus Open Appendectomy? Let the Patient Decide
Status: Enrolling
Updated: 11/27/2012
Primary Children's Hospital
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
University of Alabama at Birmingham
mi
from
Birmingham, AL
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
University of California at San Diego
mi
from
San Diego, CA
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
University of California at San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
Loma Linda University Medical Center
mi
from
Loma Linda, CA
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
Loma Linda University Medical Center
mi
from
Loma Linda, CA
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
Transplant Research Institute (TRI; formerly NIT)
mi
from
Los Angeles, CA
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
Transplant Research Institute (TRI; formerly NIT)
mi
from
Los Angeles, CA
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
University of Southern California
mi
from
Los Angeles, CA
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
UCLA Medical Center
mi
from
Los Angeles, CA
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
UCLA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
UC Davis Medical Center
mi
from
Sacramento, CA
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
UC Davis Medical Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
UCSF Medical Center
mi
from
San Francisco, CA
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
UCSF Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
California Pacific Medical Center
mi
from
San Francisco, CA
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
California Pacific Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
University of Colorado Health Science Center
mi
from
Aurora, CO
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
University of Colorado Health Science Center
mi
from
Aurora, CO
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
MedStar Washington Hospital Center
mi
from
Washington,
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
MedStar Washington Hospital Center
mi
from
Washington,
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
University of Florida
mi
from
Gainesville, FL
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
University of Miami
mi
from
Miami, FL
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
Lifelink Healthcare Institute
mi
from
Tampa, FL
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
Lifelink Healthcare Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
Piedmont Hospital
mi
from
Atlanta, GA
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
Piedmont Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
Emory University
mi
from
Atlanta, GA
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
University of Illinois, Chicago
mi
from
Chicago, IL
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
University of Illinois, Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
Rush University
mi
from
Chicago, IL
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
Rush University
mi
from
Chicago, IL
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
University of Kansas Medical Center
mi
from
Kansas City, KA
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
University of Maryland
mi
from
Baltimore, MD
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
Johns Hopkins University
mi
from
Baltimore, MD
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
University of Michigan
mi
from
Ann Arbor, MI
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
Saint Barnabas Medical Center
mi
from
West Orange, NJ
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
Saint Barnabas Medical Center
mi
from
West Orange, NJ
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
Columbia University
mi
from
New York, NY
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
Cornell University
mi
from
New York, NY
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
Cornell University
mi
from
New York, NY
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
Duke University
mi
from
Durham, NC
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
University of Cincinnati Medical Center
mi
from
Cincinnati, OH
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
University of Cincinnati Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
The Christ Hospital
mi
from
Cincinnati, OH
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
The Christ Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
University of Pittsburgh
mi
from
Pittsburgh, PA
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
Medical University of South Carolina
mi
from
Charleston, SC
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
Baylor University Medical Center
mi
from
Dallas, TX
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
Baylor University Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
Baylor All Saints Medical Center
mi
from
Fort Worth, TX
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
Baylor All Saints Medical Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
Houston Methodist Hospital
mi
from
Houston, TX
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
Houston Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
University of Virginia
mi
from
Charlottesville, VA
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
Virginia Commonwealth University (MCV)
mi
from
Richmond, VA
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
Virginia Commonwealth University (MCV)
mi
from
Richmond, VA
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
University of Wisconsin
mi
from
Madison, WI
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Differential Effects of Zolpidem Versus Ramelteon in Burned Children
Differential Effects of Zolpidem Versus Ramelteon on Nocturnal Sleep in Pediatric Burn Patients: A Prospective, Randomized Crossover Trial With Polysomnographic Recordings
Status: Enrolling
Updated:  12/12/2012
Shriners Hospital for Children
mi
from
Cincinnati, OH
Differential Effects of Zolpidem Versus Ramelteon in Burned Children
Differential Effects of Zolpidem Versus Ramelteon on Nocturnal Sleep in Pediatric Burn Patients: A Prospective, Randomized Crossover Trial With Polysomnographic Recordings
Status: Enrolling
Updated: 12/12/2012
Shriners Hospital for Children
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Computerized Cognitive Skills Training for Adolescents With Velocardiofacial Syndrome
Computer-Based Cognitive Remediation in Adolescents With VCFS
Status: Enrolling
Updated:  12/12/2012
SUNY Upstate Medical University Hospital
mi
from
Syracuse, NY
Computerized Cognitive Skills Training for Adolescents With Velocardiofacial Syndrome
Computer-Based Cognitive Remediation in Adolescents With VCFS
Status: Enrolling
Updated: 12/12/2012
SUNY Upstate Medical University Hospital
mi
from
Syracuse, NY
Click here to add this to my saved trials
Effects of Vitamin D on Inflammation in Liver Disease
Effects of Vitamin D on Inflammation in Liver Disease
Status: Enrolling
Updated:  12/18/2012
UC San Diego, CTRI
mi
from
La Jolla, CA
Effects of Vitamin D on Inflammation in Liver Disease
Effects of Vitamin D on Inflammation in Liver Disease
Status: Enrolling
Updated: 12/18/2012
UC San Diego, CTRI
mi
from
La Jolla, CA
Click here to add this to my saved trials
Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood
A Pilot Trial of WT1 Peptide-Loaded Allogeneic Dendritic Cell Vaccine and Donor Lymphocyte Infusion for WT1-Expressing Hematologic Malignancies
Status: Enrolling
Updated:  12/19/2012
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood
A Pilot Trial of WT1 Peptide-Loaded Allogeneic Dendritic Cell Vaccine and Donor Lymphocyte Infusion for WT1-Expressing Hematologic Malignancies
Status: Enrolling
Updated: 12/19/2012
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Hearing Loss Prevention for Veterans
Hearing Loss Prevention for Veterans
Status: Enrolling
Updated:  12/28/2012
VA Medical Center, Portland
mi
from
Portland, OR
Hearing Loss Prevention for Veterans
Hearing Loss Prevention for Veterans
Status: Enrolling
Updated: 12/28/2012
VA Medical Center, Portland
mi
from
Portland, OR
Click here to add this to my saved trials
Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Post US Approval Voluntary Registry Study to Determine Incidence of Hypocalcemia Post Reclast® Treatment in Patients With Paget's Disease After Institution of Educational Strategies to Improve Adherence to Calcium and Vitamin D Supplementation
Status: Enrolling
Updated:  1/2/2013
Novartis Investigative Site
mi
from
Phoenix, AZ
Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Post US Approval Voluntary Registry Study to Determine Incidence of Hypocalcemia Post Reclast® Treatment in Patients With Paget's Disease After Institution of Educational Strategies to Improve Adherence to Calcium and Vitamin D Supplementation
Status: Enrolling
Updated: 1/2/2013
Novartis Investigative Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Post US Approval Voluntary Registry Study to Determine Incidence of Hypocalcemia Post Reclast® Treatment in Patients With Paget's Disease After Institution of Educational Strategies to Improve Adherence to Calcium and Vitamin D Supplementation
Status: Enrolling
Updated:  1/2/2013
Novartis Investigative site
mi
from
Los Angeles, CA
Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Post US Approval Voluntary Registry Study to Determine Incidence of Hypocalcemia Post Reclast® Treatment in Patients With Paget's Disease After Institution of Educational Strategies to Improve Adherence to Calcium and Vitamin D Supplementation
Status: Enrolling
Updated: 1/2/2013
Novartis Investigative site
mi
from
Los Angeles, CA
Click here to add this to my saved trials